Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

References

• Aithal GP, Haugk B, Das S, Card T, Burt AD, Record CO. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? Aliment Pharmacol Ther 2004;19:391–9.
   PubMed Web of Science ®Google Scholar
• Brion N, Paule B. Non-cancer uses of methotrexate. Presse Med 1996;25:1929–34.
   PubMed Web of Science ®Google Scholar
• Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996;39:723–31.
   PubMed Web of Science ®Google Scholar
• Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994;37:316–28.
   PubMed Web of Science ®Google Scholar
• Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis 28:508–18.
   PubMed Web of Science ®Google Scholar
• Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol 2003;27:1021–5.
   PubMedGoogle Scholar
• Almasio PL, Niero M, Angioli D, Ascione A, Gullini S, Minoli G, Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol 2005;43:381–7.
   PubMed Web of Science ®Google Scholar
• Wong JB, Koff RS. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Ann Intern Med 2000;133:665–75.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705–13.
   PubMed Web of Science ®Google Scholar
• Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343–50.
   PubMed Web of Science ®Google Scholar
• Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005;42:838–45.
   PubMed Web of Science ®Google Scholar
• de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006;41:175–9.
   PubMed Web of Science ®Google Scholar
• Mendoza J, Gomez-Dominguez E, Moreno-Otero R. Transient elastography (Fibroscan), a new non-invasive method to evaluate hepatic fibrosis. Med Clin (Barc) 2006;126:220–2.
   PubMed Web of Science ®Google Scholar
• Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut 2006;55:1055–6.
   PubMed Web of Science ®Google Scholar
• Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48–54.
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Corpechot C, Poupon R. Elastography in hepatology. Can J Gastroenterol 2007;21:839–42.
   PubMed Web of Science ®Google Scholar
• Barbero-Villares A, Mendoza J, Trapero-Marugan M, Gonzalez-Alvaro I, Dauden E, Gisbert JP, Evaluation of liver fibrosis by transient elastography in methotrexate treated patients. Med Clin (Barc) 2011.
   PubMed Web of Science ®Google Scholar
• Bruhl J, Schirren M, Wei C, Antoni C, Bocker U. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers. Eur J Gastroenterol Hepatol 23:923–30.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 20:2390–6.
   PubMed Web of Science ®Google Scholar
• Gomez-Dominguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, Garcia-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24:513–18.
   PubMed Web of Science ®Google Scholar
• Laharie D, Zerbib F, Adhoute X, Boue-Lahorgue X, Foucher J, Castera L, Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006;23:1621–8.
   PubMed Web of Science ®Google Scholar
• Lupsor M, Badea R, Stefanescu H, Grigorescu M, Serban A, Radu C, Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 19:53–60.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289–93.
   PubMed Web of Science ®Google Scholar
• Carneiro SC, Cassia FF, Lamy F, Chagas VL, Ramos-e-Silva M. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages. J Eur Acad Dermatol Venereol 2008;22:25–9.
   PubMed Web of Science ®Google Scholar
• Ros S, Juanola X, Condom E, Canas C, Riera J, Guardiola J, Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Scand J Rheumatol 2002;31:330–6.
   PubMed Web of Science ®Google Scholar
• Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, Biochemical and biophysical assessment of METHOTREXATE-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int 2007;27:639–45.
   PubMed Web of Science ®Google Scholar
• Thomas JA, Aithal GP. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary? Am J Clin Dermatol 2005;6:357–63.
   PubMed Web of Science ®Google Scholar